Article
No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia.
Leukemia & lymphoma - 1 Jun 2005
Jazbec Janez, Kitanovski Lidija, Aplenc Richard, Debeljak Marusa, Dolzan Vita
Abstract excerpt
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms have been associated not only with the risk for acute lymphoblastic leukemia (ALL) in adults and children, but also with increased methotrexate toxicity. The present study aimed to investigate whether MTHFR polymorphisms modify the risk for development of secondary malignancies in children treated for ALL with protocols that included high-dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
